1 year return (CAGR)
2.16%
Cytokinetics Inc Exchange (NASDAQ, USD)
CYTK
63.31
+2.03 (+3.31%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
25.72%
5 year return (CAGR)
11.82%
10 year return (CAGR)
21.34%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
8.80B
Price/Sales
124.04
Ent value
10.64B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
27.07%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 62.08 |
| Daily high | 63.92 |
| Daily low | 61.54 |
| Daily Volume | 1.43M |
| All-time high | 108.06 |
| 1y analyst estimate | 109.90 |
| Beta | 0.36 |
| EPS (TTM) | -6.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CYTK | S&P500 | |
| Current price drop from All-time high | -41.41% | -1.25% |
| Highest price drop | -97.09% | -56.47% |
| Date of highest drop | 10 Oct 2014 | 9 Mar 2009 |
| Avg drop from high | -75.24% | -10.65% |
| Avg time to new high | 1132 days | 12 days |
| Max time to new high | 4952 days | 1805 days |
News
